The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiology Point-of-Care (POC) Diagnostics Market Research Report 2025
Synopsis
The global Cardiology Point-of-Care (POC) Diagnostics market was valued at US$ 134.6 million in 2023 and is anticipated to reach US$ 233.7 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cardiology Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiology Point-of-Care (POC) Diagnostics.
Report Scope
The Cardiology Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiology Point-of-Care (POC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiology Point-of-Care (POC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Abbott
Roche
Opko
GE Healthcare
Samsung Health
BioMerieux
Abbott
Terumo
Accriva
Akers
Radiometer
Response Biomedical
Segment by Type
Cardiometabolic Monitoring
Cardiometabolic Diagnostics
Segment by Application
Professional Diagnostic Centers
Hospitals/Critical Care Centers
Research Laboratories
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiology Point-of-Care (POC) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cardiology Point-of-Care (POC) Diagnostics market was valued at US$ 134.6 million in 2023 and is anticipated to reach US$ 233.7 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cardiology Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiology Point-of-Care (POC) Diagnostics.
Report Scope
The Cardiology Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiology Point-of-Care (POC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiology Point-of-Care (POC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Abbott
Roche
Opko
GE Healthcare
Samsung Health
BioMerieux
Abbott
Terumo
Accriva
Akers
Radiometer
Response Biomedical
Segment by Type
Cardiometabolic Monitoring
Cardiometabolic Diagnostics
Segment by Application
Professional Diagnostic Centers
Hospitals/Critical Care Centers
Research Laboratories
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiology Point-of-Care (POC) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cardiometabolic Monitoring
1.2.3 Cardiometabolic Diagnostics
1.3 Market by Application
1.3.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Professional Diagnostic Centers
1.3.3 Hospitals/Critical Care Centers
1.3.4 Research Laboratories
1.3.5 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Perspective (2019-2030)
2.2 Cardiology Point-of-Care (POC) Diagnostics Growth Trends by Region
2.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Cardiology Point-of-Care (POC) Diagnostics Market Dynamics
2.3.1 Cardiology Point-of-Care (POC) Diagnostics Industry Trends
2.3.2 Cardiology Point-of-Care (POC) Diagnostics Market Drivers
2.3.3 Cardiology Point-of-Care (POC) Diagnostics Market Challenges
2.3.4 Cardiology Point-of-Care (POC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Revenue
3.1.1 Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiology Point-of-Care (POC) Diagnostics Revenue
3.4 Global Cardiology Point-of-Care (POC) Diagnostics Market Concentration Ratio
3.4.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2023
3.5 Cardiology Point-of-Care (POC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Cardiology Point-of-Care (POC) Diagnostics Product Solution and Service
3.7 Date of Enter into Cardiology Point-of-Care (POC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiology Point-of-Care (POC) Diagnostics Breakdown Data by Type
4.1 Global Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Cardiology Point-of-Care (POC) Diagnostics Breakdown Data by Application
5.1 Global Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cardiology Point-of-Care (POC) Diagnostics Market Size (2019-2030)
6.2 North America Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
6.4 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size (2019-2030)
7.2 Europe Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size (2019-2030)
9.2 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Detail
11.1.2 Siemens Business Overview
11.1.3 Siemens Cardiology Point-of-Care (POC) Diagnostics Introduction
11.1.4 Siemens Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.1.5 Siemens Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Introduction
11.2.4 Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Cardiology Point-of-Care (POC) Diagnostics Introduction
11.3.4 Roche Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Opko
11.4.1 Opko Company Detail
11.4.2 Opko Business Overview
11.4.3 Opko Cardiology Point-of-Care (POC) Diagnostics Introduction
11.4.4 Opko Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.4.5 Opko Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Introduction
11.5.4 GE Healthcare Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.5.5 GE Healthcare Recent Development
11.6 Samsung Health
11.6.1 Samsung Health Company Detail
11.6.2 Samsung Health Business Overview
11.6.3 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Introduction
11.6.4 Samsung Health Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.6.5 Samsung Health Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Introduction
11.7.4 BioMerieux Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.7.5 BioMerieux Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Introduction
11.8.4 Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.8.5 Abbott Recent Development
11.9 Terumo
11.9.1 Terumo Company Detail
11.9.2 Terumo Business Overview
11.9.3 Terumo Cardiology Point-of-Care (POC) Diagnostics Introduction
11.9.4 Terumo Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.9.5 Terumo Recent Development
11.10 Accriva
11.10.1 Accriva Company Detail
11.10.2 Accriva Business Overview
11.10.3 Accriva Cardiology Point-of-Care (POC) Diagnostics Introduction
11.10.4 Accriva Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.10.5 Accriva Recent Development
11.11 Akers
11.11.1 Akers Company Detail
11.11.2 Akers Business Overview
11.11.3 Akers Cardiology Point-of-Care (POC) Diagnostics Introduction
11.11.4 Akers Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.11.5 Akers Recent Development
11.12 Radiometer
11.12.1 Radiometer Company Detail
11.12.2 Radiometer Business Overview
11.12.3 Radiometer Cardiology Point-of-Care (POC) Diagnostics Introduction
11.12.4 Radiometer Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.12.5 Radiometer Recent Development
11.13 Response Biomedical
11.13.1 Response Biomedical Company Detail
11.13.2 Response Biomedical Business Overview
11.13.3 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Introduction
11.13.4 Response Biomedical Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2019-2024)
11.13.5 Response Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
